tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cingulate Inc’s NDA for CTx-1301 Accepted by FDA
PremiumCompany AnnouncementsCingulate Inc’s NDA for CTx-1301 Accepted by FDA
27d ago
Cingulate announces FDA accepted for review the NDA for CTx-1301
Premium
The Fly
Cingulate announces FDA accepted for review the NDA for CTx-1301
27d ago
Cingulate Inc Approves Stock Issuance Proposal
Premium
Company Announcements
Cingulate Inc Approves Stock Issuance Proposal
2M ago
Cingulate price target lowered to $10 from $11 at Roth Capital
PremiumThe FlyCingulate price target lowered to $10 from $11 at Roth Capital
3M ago
Cingulate Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Cingulate Inc. Reports Q2 2025 Financial Results
3M ago
Cingulate reports Q2 net loss ($4.8M) vs ($3.2M) last year
Premium
The Fly
Cingulate reports Q2 net loss ($4.8M) vs ($3.2M) last year
3M ago
Cingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301
PremiumThe FlyCingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301
3M ago
Cingulate reports termination of Chief Operating Officer
Premium
The Fly
Cingulate reports termination of Chief Operating Officer
3M ago
Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
Premium
Ratings
Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100